Company Analysis
Sign in

Aurora Cannabis Inc. (ACB)

Nasdaq: ACB · Medicinal Chemicals & Botanical Products · Edmonton, AB · filing with the SEC since 2016
Full chart Alerts Compare
Grade6.3
◀ Past 7.1● Present 5.8▶ Future 6.1
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
RevenueC$343M+27.3%
Net incomeC$1.6M+102.3%
Earnings per shareC$0.04+102.6%
Operating cash flowC$16.0M+123.4%
CashC$138M+4.0%
DebtC$42.5M+11.1%
Shareholders’ equityC$609M+1.1%
Shares, diluted54.8M+26.9%
Return on equity0.3%
The recordfrom its filings
Filings in 202663
Newest filingNov 10 · SCHEDULE 13G
Annual reportJun 11, 2026
Quarterly reportn/a
Next report due40-F by Jul 29
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer category<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
18192021222425
As filed, in CAD. Nothing here is a forecast.

News

Nov 10, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form SC14D9F/A
Form SC14D9F/A
Open the filing on sec.gov
Oct 26, 2026 · SEC EDGAR · Form SC14D9F/A
Form SC14D9F/A
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton ACB · research, not advice